Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial

Leukemia

Volumn 13, Issue 1, 1999, Pages 25-31

  Webb, D K H ^a   Wheatley, K ^b   Harrison, G ^b   Stevens, R F ^c   Hann, I M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Acute myeloid leukemia; Children; Prognosis; Relapse

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; RETINOIC ACID; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CYTOGENETICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; REMISSION;

EID: 0032924997     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401254     Document Type: Article

References (28)

1. Stiller CA, Eatcock EM. Survival from acute non-lymphocytic leukaemia, 1971-88; a population based study. Arch Dis Child 1994; 70: 219-223.
2. Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G. A population based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Downs syndrome. Br J Haematol 1996; 94: 82-88.
3. Hann IM, Stevens RF, Goldstone AH, Rees JK, Wheatley K, Gray RG, Burnett AK. Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults. Results of the Medical Research Council's 10th AML trial (AML 10). Blood 1997; 89: 2311-2318.
4. Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, Beran M, McCredie KB, Freireich EJ. Response to salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 1989; 7: 1071-1080.
5. Thalhammer F, Geissler K, Jager U, Kyrle PA, Pabinger I, Mitterbauer M, Lechner K, Gisslinger H, Knobl P, Laczika K, Schneider B, Haas CA. Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy; a retrospective single-center study. Ann Hematol 1996; 72: 216-222.
6. Estey E, Kornblau S, Pierce S, Kantarjian H, Beran M, Keating M. A stratification system for evaluating therapies in patients with relapsed or primary refractory acute myeloid leukemia. Blood 1996; 88: 756.
7. Creutzig U, Ritter J, Zimmermann M, Bender-Gotze C, Stahnke K. Survival and risk factors for treatment failure after salvage therapy for children with AML relapse. Ann Hematol 1997; 74 (Suppl. 1): A14.
8. Capizzi RL, Poole M, Cooper MR, Richards F, Stuart JJ, Jackson DV, White DR, Spurr CL, Hopkins JO, Muss HB, Rudnick SA, Wells R, Gabriel D, Ross D. Treatment of poor risk acute leukemia with sequential high-dose ara-c and asparaginase. Blood 1984; 63: 694-700.
9. Huhmann IM, Watzke HH, Geissler K, Gisslinger H, Jager U, Knobl P, Pabinger I, Korninger L, Mannhalter C, Mitterbauer G, Schwarzinger I, Kalhs P, Haas OA, Lechrer K. FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia. Ann Hematol 1996; 73: 256-258.
10. Creutzig U, Ritter J, Zimmerman M, Langermann HJ, Henze G, Kabisch H, Niethammer D, Jurgens H, Stollman B. Improved treatment results in childhood acute myeloid leukemia: a report of the German cooperative study AML-BFM-78. Blood 1985; 65: 298-304.
11. Nesbit ME, Buckley JD, Feig SA, Anderson JR, Lampkin B, Bernstein ID, Kim TH, Piomelli S, Kersey JH, Coccia PF. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1994; 12: 127-135.
12. Tiedemann K, Waters KD, Tauro GP, Tucker D, Ekert H. Results of intensive therapy in childhood autce myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Blood 1993; 82: 3730-3738.
13. Wells RJ, Woods WG, Buckley JD, Odom LF, Benjamin D, Bernstein I, Betcher D, Feig S, Kim T, Ruymans F. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Children's Cancer Group study. J Clin Oncol 1994; 12: 2367-2377.
14. Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, Barnard D, Benjamin D, De Swarte J, Kalowsek D. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Children's Cancer Group pilot study. J Clin Oncol 1993; 11: 1448-1457.
15. Woods WG, Kobrinsky N, Buckley JD, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, De Swarte J, Dusenberg K, Kalousek D, Arthur D, Lange BJ. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 1996; 87: 4979-4989.
16. Angelov L, Brandwein JM, Baker MA et al. Results of therapy for acute myeloid leukemia in first relapse. Leuk Lymphoma 1991; 6: 15-21.
17. Archimbaud E, Thomas X, Leblond V, Michailen M, Fenaux P, Cordonnier C, Dreyfus F, Troussed X, Jaubert J, Travade P. Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial. J Clin Oncol 1995; 13: 11-18.
18. Brown RA, Wolff SN, Fay JW, Piniero L, Collins RH, Lynch JP, Stevens D, Green J, Herzig RH, Herzig GP. High-dose etoposide, cyclophosphamide, and total body irradiation with allogenic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American marrow transplant group. Blood 1995; 85: 1391-1395.
19. Chopra R, Goldstone AH, McMillan AK, Powles R, Smith AG, Prentice HG, Reid C, Marcus RA, Bell A, Milligan D. Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/ cyclophosphamide and unpurged marrow: the British autograft group experience. J Clin Oncol 1991; 9: 1840-1847.
20. Hakami N, Look AT, Steuber, Krischer J, Castleberry R, Harris R, Ravidranath H, Vietti T. Combined etoposide and 5 azacitidine in children and adolescents with refractory or relapsed acute non-lymphocytic leukaemia: a Pediatric Oncology Group study. J Clin Oncol 1987; 5: 1022-1025.
21. Steuber CP, Krischer J, Holbrook T, Camitta B, Land V, Sexauer C, Mahoney D, Weinstein H. Therapy of refractory or recurrent childhood acute rnyeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 1996; 14: 1521-1525.
22. Vignetti M, Rondelli R, Locatelli F, Lanino E, Miniero R, Rosetti F, Mesoni G. Autologous bone marrow transplantation in children with acute myeloblastic leukemia: report from the Italian national pediatric registry. Bone Marrow Transplant 1996; 18 (Suppl. 2): 59-62.
23. Whitlock JA, Wells RJ, Hord JD, Janco RL, Greer JP, Gay JC, Edwards IR, McCurley TL, Lukens JN. High dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia 1997; 11: 185-189.
24. Stahnke K, Ritter J, Schellong G, Beck JD, Kabisch H, Lampert F, Creutzig U. Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study. Klin Padiatr 1992; 204: 253-257.
25. Casper J, Camitta B, Truitt R, Baxter-Lowe LA. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354-2363.
26. Petersen FB, Lynch MH, Clift RA, Appelbaum FR, Sanders JE, Bensinger WI, Benyumes MC, Doney K, Fefer A, Matin P. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J Clin Oncol 1993; 11: 1353-1359.
27. Mrsic M, Horowitz MM, Atknson K, Biggs JC, Champlin RE, Ehninger G, Gajeoski JL, Gale RP, Herzig RH, Prentice HG. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
28. Hermann J, Fuchs D, Prager J, Palme H, Muller A, Fuller J, Vogelsang H, Zintl F. Results of allogenic and autologous bone marrow transplantation in children with acute myeloid leukemia. Kind Prax 1992; 60: 35-39.